|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_on1000453879 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n|---||||| |
008 |
170812s2017 nju o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d UEJ
|d OCLCO
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 1000116823
|a 1011103252
|a 1011515745
|a 1031766777
|a 1031941582
|
020 |
|
|
|a 9781119092582
|
020 |
|
|
|a 1119092582
|
020 |
|
|
|z 1119092566
|
020 |
|
|
|z 9781119092568
|
029 |
1 |
|
|a AU@
|b 000065431138
|
035 |
|
|
|a (OCoLC)1000453879
|z (OCoLC)1000116823
|z (OCoLC)1011103252
|z (OCoLC)1011515745
|z (OCoLC)1031766777
|z (OCoLC)1031941582
|
050 |
|
4 |
|a RM301.25
|b .P73 2017
|
082 |
0 |
4 |
|a 615.19
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Marsault, Eric.
|
245 |
1 |
0 |
|a Practical Medicinal Chemistry with Macrocycles.
|
260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2017.
|
300 |
|
|
|a 1 online resource (652 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Title Page ; Copyright Page; Contents; Foreword; Introduction; About the Contributors; Part I Challenges Specific to Macrocycles; Chapter 1 Contemporary Macrocyclization Technologies; 1.1 Introduction; 1.2 Challenges Inherent to the Synthesis of Macrocycles; 1.3 Challenges in Macrocycle Characterization; 1.4 Macrocyclization Methods; 1.5 Cyclization on the Solid Phase; 1.6 Summary; References; Chapter 2 A Practical Guide to Structural Aspects of Macrocycles (NMR, X-Ray, and Modeling) ; 2.1 Background; 2.1.1 Classes of Macrocycles Covered.
|
505 |
8 |
|
|a 2.1.2 Applications of Macrocycles in Drug Design and Agriculture and the Role of Structural Information in These Applications2.1.3 Experimental Techniques (NMR and X-Ray) ; 2.1.4 Modeling Studies; 2.2 Experimental Studies of Macrocycles; 2.2.1 NMR Experiments and Parameters That Yield Structural Information; 2.2.2 Protocols for 3D Structural Determination Using NMR; 2.2.3 Dynamic Aspects of Structures (NMR Relaxation); 2.2.4 X-Ray Studies of Macrocycles ; 2.2.5 Macrocycle-Receptor Interactions (NMR and X-Ray) ; 2.3 Molecular Modeling of Macrocyclic Peptides.
|
505 |
8 |
|
|a 2.3.1 Methods and Challenges in Modeling Cyclic Peptides2.3.1.1 Quantum Mechanics; 2.3.1.2 Molecular Mechanics; 2.3.2 Conformation, Dynamics, and Electrostatics of Cyclic Peptides; 2.3.2.1 NMR Spectroscopy Combined with MD Simulations; 2.3.2.2 Studying Large Conformational Ensembles and Folding; 2.3.2.3 Electrostatic Characteristics of Cyclic Peptides; 2.3.3 Modeling the Activity of Cyclic Peptides; 2.3.3.1 Cyclic Peptide Interactions with Molecular Targets; 2.3.3.2 Cyclic Peptide Nanotubes; 2.3.3.3 Membrane Permeation and Diffusion; 2.3.4 Engineering Cyclic Peptides as Grafting Scaffolds.
|
505 |
8 |
|
|a 2.4 SummaryAcknowledgments; References; Chapter 3 Designing Orally Bioavailable Peptide and Peptoid Macrocycles ; 3.1 Introduction; 3.2 Improving Peptide Plasma Half-Life ; 3.3 Absorption, Bioavailability, and Methods for Predicting Absorption; 3.3.1 In Vitro Assays; 3.3.2 Paracellular Absorption; 3.3.3 Tight Junction Modifiers to Improve Paracellular Absorption; 3.3.4 Transcellular Absorption of Macrocycles; 3.3.4.1 Cyclization; 3.3.4.2 N-Methylation ; 3.3.4.3 Cyclosporine A (CSA); 3.3.4.4 Conformational Interconversion and H-Bond Networks ; 3.3.4.5 Shielding.
|
505 |
8 |
|
|a 3.3.4.6 Additional Strategies for Managing Hydrogen Bond Donors3.4 In Silico Modeling; 3.5 Future Directions; References; Part II Classes of Macrocycles and Their Potential for Drug Discovery; Chapter 4 Natural and Nature-Inspired Macrocycles: A Chemoinformatic Overview and Relevant Examples ; 4.1 Introduction to Natural Macrocycles as Drugs and Drug Leads; 4.2 Biosynthetic Pathways, Natural Role, and Biotechnological Access; 4.3 QSAR and Chemoinformatic Analyses of Common Features; 4.4 Case Studies: Selected Natural Macrocycles of Special Relevance in Medicinal Chemistry; References.
|
500 |
|
|
|a Chapter 5 Bioactive and Membrane-Permeable Cyclic Peptide Natural Products.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
6 |
|a Chimie pharmaceutique.
|
650 |
|
7 |
|a Drug development
|2 fast
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|
700 |
1 |
|
|a Peterson, Mark L.
|
758 |
|
|
|i has work:
|a Practical medicinal chemistry with macrocycles (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFxVHg44JFHV3JvkvXvj4q
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Marsault, Eric.
|t Practical Medicinal Chemistry with Macrocycles.
|d Newark : John Wiley & Sons, Incorporated, ©2017
|z 9781119092568
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4939443
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4939443
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 14742300
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 14971725
|
994 |
|
|
|a 92
|b IZTAP
|